Study Shows Importance of Comprehensive Genomic Profiling for NSCLC

Project Oncology® - Ein Podcast von ReachMD

Guest: Vivek Subbiah, MD This episode will recap updates from the 2023 ASCO Annual Meeting regarding the abstract on comprehensive genomic profiling for non-small cell lung cancer (NSCLC). Join Dr. Vivek Subbiah, Chief of Early Drug Development at the Sarah Cannon Research Institute in Nashville, Tennessee, to learn more.

Visit the podcast's native language site